Metabolic, demographic, and anthropometric characteristics at baseline and dietary and physical activity variables during the study (n = 22)
| Baseline characteristics | |
| Age (years) | 66.6 ± 4.7 |
| Current smoker | 1 (4.5) |
| BMI (kg/m2) | 32.9 ± 4.7 |
| Waist circumference (cm) | 102 ± 9.0 |
| Body mass (kg) | 83.6 ± 11.7 |
| Total cholesterol (mmol/L) | 5.60 ± 0.87 |
| Triglycerides (mmol/L) | 2.17 ± 0.86 |
| NEFA (mmol/L) | 0.44 ± 0.24 |
| HbA1c (%) | 5.8 ± 0.2 |
| HbA1c (mmol/mol) | 40 ± 2.3 |
| Fasting plasma glucose (mmol/L) | 5.4 ± 0.4 |
| Lipid-lowering medication | 5 (22.7) |
| β-Blockers | 5 (22.7) |
| ACE inhibitors | 3 (13.6) |
| Ethnicity | |
| White European | 20 (90.9) |
| Black and minority ethnic | 2 (9.1) |
| In-study characteristics | |
| Diet | |
| Total energy intake (kcal/day) | 1,717 ± 234 |
| Total fat (energy %) | 58 ± 0.2 |
| Total carbohydrate (energy %) | 26 ± 0.1 |
| Total protein (energy %) | 16 ± 0.2 |
| Walking speed (km/h) | 3.0 (1.5–4.0) |
| Borg RPE score | 10 (8–12) |
| Baseline characteristics | |
| Age (years) | 66.6 ± 4.7 |
| Current smoker | 1 (4.5) |
| BMI (kg/m2) | 32.9 ± 4.7 |
| Waist circumference (cm) | 102 ± 9.0 |
| Body mass (kg) | 83.6 ± 11.7 |
| Total cholesterol (mmol/L) | 5.60 ± 0.87 |
| Triglycerides (mmol/L) | 2.17 ± 0.86 |
| NEFA (mmol/L) | 0.44 ± 0.24 |
| HbA1c (%) | 5.8 ± 0.2 |
| HbA1c (mmol/mol) | 40 ± 2.3 |
| Fasting plasma glucose (mmol/L) | 5.4 ± 0.4 |
| Lipid-lowering medication | 5 (22.7) |
| β-Blockers | 5 (22.7) |
| ACE inhibitors | 3 (13.6) |
| Ethnicity | |
| White European | 20 (90.9) |
| Black and minority ethnic | 2 (9.1) |
| In-study characteristics | |
| Diet | |
| Total energy intake (kcal/day) | 1,717 ± 234 |
| Total fat (energy %) | 58 ± 0.2 |
| Total carbohydrate (energy %) | 26 ± 0.1 |
| Total protein (energy %) | 16 ± 0.2 |
| Walking speed (km/h) | 3.0 (1.5–4.0) |
| Borg RPE score | 10 (8–12) |
Data are mean ± SD, n (%), or mean (range).